BackInnovAge Holding Overview
InnovAge Holding Corp

InnovAge Holding Target Price

Analysts' average 12-month price target for InnovAge Holding is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9

Average Target Price

$13.5050% upside

2 analysts in the last 4 months

High: $14 | Low: $13

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09KeyBanc$1455.6% upsideOpen
2026-08-21KeyBancMatthew Gillmor$1344.4% upsideOpen
2023-02-08J.P. Morgan$811.1% downsideOpen
2022-11-23Goldman Sachs$811.1% downsideOpen
2022-11-16Citigroup$811.1% downsideOpen
2022-09-15Barclays$544.4% downsideOpen
2022-04-20Piper Sandler$544.4% downsideOpen

InnovAge Holding (INNV) FAQ

InnovAge Holding (INNV) currently reports a target price of $14. Use the charts on this page to explore InnovAge Holding's target price history and peer comparisons.

Analysts' average 12-month price target for InnovAge Holding is $14, about 50.0% upside from the current share price of $9.0. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $14, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for InnovAge Holding, and consider following INNV for alerts when major investors trade the stock.

InnovAge Holding is classified in the Healthcare sector. On target price, it currently shows $14. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INNV with unrelated industries.